OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)
South Korea
· Delayed Price · Currency is KRW 5,630.00
-60.00 (-1.05%)
Dec 20, 2024, 9:00 AM KST
OPTUS Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 9,513 | 10,760 | 5,012 | 9,892 | 14,405 | 14,596 | Upgrade
|
| Depreciation & Amortization | 3,975 | 4,238 | 3,463 | 2,423 | 2,585 | 2,620 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.15 | -295.22 | -796.74 | -10.25 | - | 59.69 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,597 | -2,301 | 566.27 | 930.99 | -2,486 | -364.96 | Upgrade
|
| Stock-Based Compensation | -38.77 | 81.41 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -11.39 | -15.04 | -0.09 | - | - | - | Upgrade
|
| Other Operating Activities | 2,324 | 2,771 | 646.69 | -397.52 | 2,935 | 922.51 | Upgrade
|
| Change in Accounts Receivable | -750.02 | -1,852 | -1,151 | -2,438 | 3,433 | -1,099 | Upgrade
|
| Change in Inventory | -2,111 | -1,800 | -2,112 | -3,043 | -928.45 | -834.3 | Upgrade
|
| Change in Accounts Payable | 579.02 | 352.75 | 17.23 | 306.46 | 95.21 | 357.59 | Upgrade
|
| Change in Other Net Operating Assets | -735.5 | 497.8 | -3,601 | -592.48 | -2,593 | 571.46 | Upgrade
|
| Operating Cash Flow | 11,149 | 12,438 | 2,045 | 7,071 | 17,446 | 16,830 | Upgrade
|
| Operating Cash Flow Growth | 32.13% | 508.12% | -71.08% | -59.47% | 3.66% | 11.86% | Upgrade
|
| Capital Expenditures | -11,284 | -3,329 | -6,001 | -10,628 | -5,842 | -3,805 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.82 | 683.79 | 1,292 | 2.9 | - | 151.8 | Upgrade
|
| Sale (Purchase) of Intangibles | -5,492 | - | - | - | - | - | Upgrade
|
| Investment in Securities | 30,421 | -173.08 | -10,998 | -4,606 | -5,893 | -10,207 | Upgrade
|
| Other Investing Activities | -16.3 | -78.03 | -536.23 | 12.32 | 20 | 12.89 | Upgrade
|
| Investing Cash Flow | 13,667 | -2,929 | -16,266 | -15,223 | -6,410 | -13,834 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 2 | - | Upgrade
|
| Total Debt Issued | 1 | - | - | - | 2 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -2 | - | Upgrade
|
| Long-Term Debt Repaid | - | -588.39 | -364.67 | -111.24 | -108.86 | -81.3 | Upgrade
|
| Total Debt Repaid | -697.96 | -588.39 | -364.67 | -111.24 | -110.86 | -81.3 | Upgrade
|
| Net Debt Issued (Repaid) | -696.96 | -588.39 | -364.67 | -111.24 | -108.86 | -81.3 | Upgrade
|
| Issuance of Common Stock | 63.24 | - | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -5,958 | - | -2,020 | - | Upgrade
|
| Dividends Paid | -1,526 | -1,517 | -1,604 | -1,604 | -1,632 | -1,632 | Upgrade
|
| Financing Cash Flow | -2,160 | -2,105 | -7,927 | -1,715 | -3,761 | -1,714 | Upgrade
|
| Foreign Exchange Rate Adjustments | -16.93 | -2.25 | 1.05 | - | -8.9 | -0.64 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - | Upgrade
|
| Net Cash Flow | 22,639 | 7,402 | -22,146 | -9,867 | 7,266 | 1,282 | Upgrade
|
| Free Cash Flow | -134.44 | 9,109 | -3,955 | -3,557 | 11,603 | 13,025 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -10.91% | -9.28% | Upgrade
|
| Free Cash Flow Margin | -0.17% | 12.58% | -6.74% | -6.21% | 19.08% | 21.55% | Upgrade
|
| Free Cash Flow Per Share | -8.80 | 599.63 | -249.37 | -221.86 | 719.32 | 797.76 | Upgrade
|
| Cash Interest Paid | 27.88 | 120.16 | 83.85 | - | 0 | - | Upgrade
|
| Cash Income Tax Paid | 2,171 | 930.79 | 2,094 | 2,075 | 2,871 | 1,694 | Upgrade
|
| Levered Free Cash Flow | -9,099 | 5,838 | -4,902 | -4,264 | 13,314 | 2,212 | Upgrade
|
| Unlevered Free Cash Flow | -9,034 | 5,915 | -4,848 | -4,258 | 13,325 | 2,215 | Upgrade
|
| Change in Net Working Capital | 1,133 | 139.63 | 5,592 | 2,598 | -7,328 | 6,093 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.